More medicine, more tests and more treatments doesn’t necessarily mean better health. Some patients might have unrealistic expectations when it comes to the benefits that can come from medical interventions and in turn might overlook some of the potential harms that come with treatment. The results of this not only include potentially disappointing outcomes, but […]
For nearly a quarter century, doctors have ordered annual PSA tests for men of a certain age to screen for prostate cancer, despite a lack of evidence that the benefits outweighed the risks -- especially when tiny, slow-growing tumors were detecte...
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
According to the CDC, prostate cancer represents the most common non-skin cancer in American men and the second leading cause of death in US men. Recent research initiatives have shed some light on the mechanisms of this disease and possible therapies for treating both localized and metastatic prostate cancers. Even so, researchers and scientists remain […]